CBD isolate producers in the UK are waiting to see whether and how the new toxicological data released earlier this month by the European Industrial Hemp Association (EIHA) will affect their applications to the Food Standards Agency (FSA) for novel food authorisation.

Based on the toxicological studies it conducted, the EIHA, whose consortium of 170 members applied to both the FSA and the European Food Safety Authority (Efsa), set the reasonable level of CBD intake at 17.5 mg per day, well below the 70 mg FSA considers to be an acceptable daily intake.

...

Need help?

Contact a sales representative right now and don’t wait

Erik Galavis
+34 654 320 547
Email Erik

Restricted content. Do you want to read more?

Request report

Interested in buying?
Request more information

MORE INFO

Visit store

Check out our reports
available for purchase

VIEW REPORTS

Request a free sample of this report:

“ EIHA’s ‘reasonable daily intake’ sows confusion over novel food applications ”

    This file is not available, please fill the form to request your sample page:






    Buy report request information:

    “ EIHA’s ‘reasonable daily intake’ sows confusion over novel food applications ”






      CBD isolate producers in the UK are waiting to see whether and how the new toxicological data released earlier this month by the European Industrial Hemp Association (EIHA) will affect their applications to the Food Standards Agency (FSA) for novel food authorisation.

      Based on the toxicological studies it conducted, the EIHA, whose consortium of 170 members applied to both the FSA and the European Food Safety Authority (Efsa), set the reasonable level of CBD intake at 17.5 mg per day, well below the 70 mg FSA considers to be an acceptable daily intake.

      ...

      Benefits of subscription plans:

      • Stay informed of any legal and market change in the sector that impacts your organization
      • Maximise resources by getting market and legal data analysis daily in one place
      • Make smart decisions by understanding how the regulatory and market landscape evolves
      • Anticipate risks in your decisions by monitoring regulatory changes that impact your organization

      Need help?

      Contact a sales representative right now and don’t wait

      Erik Galavis
      +34 654 320 547
      Email Erik